Securing a
healthier future
At GPN Vaccines, we are committed to advancing public health by developing innovative vaccines against preventable infectious diseases, ensuring a healthier future for all.
MISSION
Innovative global health solutions
GPN Vaccines is a clinical-stage company focused on creating innovative vaccines that offer robust protection against the world’s most important bacterial pathogens.
Innovative Vaccines
Scientific Excellence
Global Collaboration
Technology
A new era in
vaccine development
Our vaccines are based on proprietary strains of bacteria that have been modified to be safe and highly effective.
Clinical Trials
Participate in ground breaking research
Join us in pioneering the next generation of vaccines to prevent pneumococcal disease and in so doing contribute to advancing global health. Whether you have experience with clinical trials or are considering participating for the first time, explore our clinical trials page for more information and check your eligibility to see how you can get involved in advancing vaccine research.
Am I Eligible?
Learn more about the requirements to participate in our clinical trials and contribute to advancing the development of our innovative vaccines.
Events
Upcoming conferences
News
Latest updates
12/11/2024Dose Escalation Approved and Dosing Commenced in Second Cohort of GPN Vaccines’ Phase 1 Clinical Trial in Older Adults
Read articleAdelaide, Australia, 12 th November 2024 – GPN Vaccines Ltd is pleased to announce that dose escalation has…
17/10/2024GPN Vaccines Welcomes Dr. Bruce Forrest as Chief Scientific Officer
Read articleAdelaide, Australia, 17th October 2024 – GPN Vaccines Ltd is thrilled to announce the appointment of Dr. Bruce…
04/09/2024First Participant Dosed in Phase 1 Clinical Trial of Gamma-PN in Older Adults
Read articleAdelaide, Australia, 5th September 2024 – GPN Vaccines Ltd is pleased to announce that the first participant has…
PARTNERSHIPS
